Company: FCRX
Filing Date: 2025-02-19
Form Type: 10-K
Source: 0000950170-25-023153
Chunk: 543

Company: Crescent Capital BDC, Inc.
Filing Date: 2025-02-19
Form: 10-K
Item: Item 8
Chunk 543
---
    )

    0.0

    —

    23,140

    20,733

    2.1

    16,444

    Pharmaceuticals, Biotechnology & Life Sciences

    Alcanza Clinical Research
    Senior Secured First Lien Term Loan
    S + 600  (100 Floor)
    10.48%
    12/2027
     
    7,191

    7,114

    1.0

    7,189

    Alcanza Clinical Research
    Senior Secured First Lien Revolver
    S + 600  (100 Floor)
    10.48%
    12/2027
     
    125

    124

    0.0

    125

94

    CRESCENT CAPITAL BDC, Inc.Consolidated Schedule of InvestmentsDecember 31, 2024(in thousands, except share and per share data)

    Country/Security/Industry/Company
    Investment Type
    InterestTerm *
    InterestRate
    Maturity/DissolutionDate
    PrincipalAmount, Par Value or Shares **

    Cost

    Percentageof NetAssets ***

    FairValue

    BioAgilytix
    Senior Secured First Lien Term Loan
    S + 650 PIK (75 Floor)
    11.21%
    12/2028
     
    15,068

    14,884

    1.7

    12,380

    BioAgilytix
    Senior Secured First Lien Delayed Draw Term Loan
    S + 650 PIK (75 Floor)
    11.21%
    12/2028
     
    783

    774

    0.1

    643

    LSCS Holdings, Inc. (Eversana) (12)
    Senior Secured Second Lien Term Loan
    S + 800  (50 Floor)
    12.47%
    12/2029
     
    14,700

    14,449

    1.9

    14,186

    Teal Acquisition Co., Inc
    Unitranche First Lien Term Loan
    S + 625  (100 Floor)
    10.96%
    09/2026
     
    2,174